RxDoctor Payments Data

Douglas Files, DO

Family Medicine · Levittown, PANPI 1215984760

Payments from drug & device makers

$15,099in general payments, 2019–2025

Across 1,022 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Novo Nordisk$2K
  • AstraZeneca$2K
  • Pfizer$1K
  • GSK$727
  • Amgen$634
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$15,064100%
  • Education$350%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)244$2,816
Novo Nordisk113$1,545
AstraZeneca83$1,535
Pfizer127$1,290
GSK46$727
Amgen(2 entities)39$634
Lilly USA, LLC40$628
Otsuka America Pharmaceutical, Inc.24$481
Boehringer Ingelheim23$454
Merck27$451
Amarin Pharma, Inc.22$306
Astellas Pharma US Inc18$298
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$240
Scilex Pharmaceuticals Inc.12$237
Takeda Pharmaceuticals U.S.A., Inc.15$223
Teva Pharmaceuticals USA, Inc.14$223
Biohaven Pharmaceutical Holding Company Ltd.10$208
Exact Sciences10$199
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)8$191
Novartis13$181
Abbott9$173
Axsome Therapeutics, Inc.8$164
Vanda Pharmaceuticals Inc.6$158
Verona Pharma, Inc.5$123
Bayer6$119
Johnson & Johnson7$119
Lundbeck LLC5$106
Supernus Pharmaceuticals, Inc.5$100
Corcept Therapeutics4$90
Tolmar, Inc.5$84
Kowa Pharmaceuticals America, Inc.7$83
IBSA Pharma Inc.3$72
Eisai Inc.4$62
Hikma Pharmaceuticals USA4$62
Dexcom, Inc.3$62
Radius Health, Inc.3$56
Corium, LLC2$54
Xeris Pharmaceuticals, Inc.3$50
E.r. Squibb & Sons, L.L.C.3$42
Zyla Life Sciences, Inc.2$32
Optinose US, Inc.2$30
Althera Pharmaceuticals LLC2$30
Aytu Biopharma, Inc.1$25
Inspire Medical Systems, Inc.1$24
Sanofi Pasteur Inc.1$24
Daiichi Sankyo Inc.1$24
Sanofi1$23
Mannkind Corporation1$23
Phathom Pharmaceuticals, Inc.1$23
Averitas Pharma Inc.1$20
Clarus Therapeutics Inc.1$18
Hologic Sales And Service, LLC1$17
Idorsia Pharmaceuticals US Inc1$17
Phadia US Inc.1$17
Biohaven Pharmaceuticals, Inc.1$16
Bristol Myers Squibb1$14
Regeneron Healthcare Solutions, Inc.1$14
Currax Pharmaceuticals LLC1$14
Ironwood Pharmaceuticals, Inc1$13
Jazz Pharmaceuticals Inc.1$13

How this compares

$15,099 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$165,839
Medicare patients
241
Services billed
2,749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin79$80,902
JanuviaSitagliptin Phosphate68$69,148
Trelegy ElliptaFluticasone/Umeclidin/Vilanter87$63,361
MounjaroTirzepatide25$34,403
OzempicSemaglutide31$33,403
FarxigaDapagliflozin Propanediol32$27,019
TrulicityDulaglutide14$22,083
Breztri AerosphereBudesonide/Glycopyr/Formoterol34$20,240
EntrestoSacubitril/Valsartan25$17,761
JanumetSitagliptin Phos/Metformin Hcl11$17,101
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$16,961
GlyxambiEmpagliflozin/Linagliptin18$16,831
EliquisApixaban15$13,328
Icosapent Ethyl20$10,325
BrilintaTicagrelor15$10,217

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Glyxambi$454$97,73397 claims
MerckJanuvia, Janumet$451$86,24979 claims
GSKTrelegy Ellipta$727$63,36187 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog$628$59,74256 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta$1,535$57,47581 claims
Novo NordiskOzempic, Novolog$1,545$36,38253 claims
NovartisEntresto$181$17,76125 claims
PfizerEliquis$1,290$13,32815 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Levittown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →